Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASCEND: Siplizumab in de Novo Renal Transplant Recipients
NCT05669001Phase 2Completed
- Sponsor
- ITB-MED
- Start
- Dec 2023
- Primary completion
- Apr 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of siplizumab in kidney transplant, sponsored by ITB-MED. Started Dec 2023; status: completed.
02
Drugs
siplizumab
03
Conditions
kidney transplant
Beyond the preview
Go deeper on NCT05669001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05669001.